Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 134

1.

Prasugrel versus clopidogrel for acute coronary syndromes.

Lynch DR Jr, Dantzler DM Jr, Zhao D.

N Engl J Med. 2013 Jan 10;368(2):188. doi: 10.1056/NEJMc1213509#SA1. No abstract available.

PMID:
23301742
2.

Prasugrel versus clopidogrel for acute coronary syndromes.

Roe MT, Ohman EM; TRILOGY ACS Investigators.

N Engl J Med. 2013 Jan 10;368(2):188-9. doi: 10.1056/NEJMc1213509. No abstract available.

3.

Prasugrel versus clopidogrel for acute coronary syndromes without revascularization.

Roe MT, Armstrong PW, Fox KA, White HD, Prabhakaran D, Goodman SG, Cornel JH, Bhatt DL, Clemmensen P, Martinez F, Ardissino D, Nicolau JC, Boden WE, Gurbel PA, Ruzyllo W, Dalby AJ, McGuire DK, Leiva-Pons JL, Parkhomenko A, Gottlieb S, Topacio GO, Hamm C, Pavlides G, Goudev AR, Oto A, Tseng CD, Merkely B, Gasparovic V, Corbalan R, Cinteză M, McLendon RC, Winters KJ, Brown EB, Lokhnygina Y, Aylward PE, Huber K, Hochman JS, Ohman EM; TRILOGY ACS Investigators.

N Engl J Med. 2012 Oct 4;367(14):1297-309. doi: 10.1056/NEJMoa1205512. Epub 2012 Aug 25.

4.
5.
7.

Prasugrel versus clopidogrel.

von Lewinski F, Riggert J, Paulus W.

N Engl J Med. 2008 Mar 20;358(12):1299; author reply 1299-301. No abstract available.

PMID:
18357639
8.

Prasugrel versus clopidogrel.

Serebruany V.

N Engl J Med. 2008 Mar 20;358(12):1298; author reply 1299-301. doi: 10.1056/NEJMc073398. No abstract available.

9.

Prasugrel versus clopidogrel for patients with unstable angina or non-ST-segment elevation myocardial infarction with or without angiography: a secondary, prespecified analysis of the TRILOGY ACS trial.

Wiviott SD, White HD, Ohman EM, Fox KA, Armstrong PW, Prabhakaran D, Hafley G, Lokhnygina Y, Boden WE, Hamm C, Clemmensen P, Nicolau JC, Menozzi A, Ruzyllo W, Widimsky P, Oto A, Leiva-Pons J, Pavlides G, Winters KJ, Roe MT, Bhatt DL.

Lancet. 2013 Aug 17;382(9892):605-13. doi: 10.1016/S0140-6736(13)61451-8. Erratum in: Lancet. 2013 Aug 31;382(9894):768.

PMID:
23953385
10.

[Platelet inhibition with prasugrel].

Gassanov N, Caglayan E, Nia AM, Erdmann E, Er F.

Dtsch Med Wochenschr. 2010 Aug;135(31-32):1542-6. doi: 10.1055/s-0030-1262444. Epub 2010 Jul 27. Review. German.

PMID:
20665417
11.

Study design and rationale of a comparison of prasugrel and clopidogrel in medically managed patients with unstable angina/non-ST-segment elevation myocardial infarction: the TaRgeted platelet Inhibition to cLarify the Optimal strateGy to medicallY manage Acute Coronary Syndromes (TRILOGY ACS) trial.

Chin CT, Roe MT, Fox KA, Prabhakaran D, Marshall DA, Petitjean H, Lokhnygina Y, Brown E, Armstrong PW, White HD, Ohman EM; TRILOGY ACS Steering Committee.

Am Heart J. 2010 Jul;160(1):16-22.e1. doi: 10.1016/j.ahj.2010.04.022.

PMID:
20598967
12.

Predictors of myocardial infarction after an acute coronary syndrome with clopidogrel and prasugrel.

Lalor N, Conde D, Rodriguez L, Elissamburu P, Trivi M.

Am J Emerg Med. 2013 Aug;31(8):1287-8. doi: 10.1016/j.ajem.2013.05.037. Epub 2013 Jun 24. No abstract available.

PMID:
23806726
13.

Prasugrel versus clopidogrel in patients with acute coronary syndromes.

Wiviott SD, Braunwald E, McCabe CH, Montalescot G, Ruzyllo W, Gottlieb S, Neumann FJ, Ardissino D, De Servi S, Murphy SA, Riesmeyer J, Weerakkody G, Gibson CM, Antman EM; TRITON-TIMI 38 Investigators.

N Engl J Med. 2007 Nov 15;357(20):2001-15. Epub 2007 Nov 4.

15.

[What kind of antiplatelet treatment in acute coronary syndrome?--Intensive antiplatelet treatment only for patients with invasive strategy].

Meinertz T.

Dtsch Med Wochenschr. 2013 Nov;138(45):2288. doi: 10.1055/s-0032-1329065. Epub 2013 Oct 25. German. No abstract available.

PMID:
24163163
16.

Clinical outcomes for prasugrel versus clopidogrel in patients with unstable angina or non-ST-elevation myocardial infarction: an analysis from the TRITON-TIMI 38 trial.

De Servi S, Goedicke J, Schirmer A, Widimsky P.

Eur Heart J Acute Cardiovasc Care. 2014 Dec;3(4):363-72. doi: 10.1177/2048872614534078. Epub 2014 May 12.

PMID:
24818952
17.

TRILOGY ACS: prasugrel of benefit only after angiography?

Swaminathan RV, Feldman DN.

Lancet. 2013 Aug 17;382(9892):580-2. doi: 10.1016/S0140-6736(13)61640-2. No abstract available.

PMID:
23953376
18.

Reduction in recurrent cardiovascular events with prasugrel compared with clopidogrel in patients with acute coronary syndromes from the TRITON-TIMI 38 trial.

Murphy SA, Antman EM, Wiviott SD, Weerakkody G, Morocutti G, Huber K, Lopez-Sendon J, McCabe CH, Braunwald E; TRITON-TIMI 38 Investigators.

Eur Heart J. 2008 Oct;29(20):2473-9. doi: 10.1093/eurheartj/ehn362. Epub 2008 Aug 5.

19.

[Prasugrel for acute and long-term treatment of patients with acute coronary syndromes: what is state-of-the-art?].

Silber S, Helms TM, Garlichs C, Arntz HR, Weil J, Ince H, Klingenheben T, Hoffmann S, Boudriot E, Steiger H, Zugck C.

Dtsch Med Wochenschr. 2011 Apr;136(15):782-5. doi: 10.1055/s-0031-1272567. Epub 2011 Mar 22. Review. German. No abstract available.

PMID:
21432747
20.

Switching patients from clopidogrel to prasugrel in acute coronary syndrome: effects of prasugrel loading dose on residual platelet reactivity.

Lhermusier T, Voisin S, Mejean S, Garcia C, Sié P, Carrié D.

J Thromb Haemost. 2012 Sep;10(9):1946-9. doi: 10.1111/j.1538-7836.2012.04838.x. No abstract available.

Supplemental Content

Support Center